Please use a PC Browser to access Register-Tadawul
Get It
Eterna Therapeutics shares are trading higher after the company announced results from a preclinical study on ERNA-101.
Eterna Therapeutics ERNA | 0.29 0.31 | +9.81% +7.71% Post |